Alnylam Pharmaceuticals
ALNY
#446
Rank
โ‚น4.755 T
Marketcap
โ‚น35,996
Share price
-3.65%
Change (1 day)
72.99%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company